53 related articles for article (PubMed ID: 2877127)
1. Indenolol kinetics versus pharmacodynamics in hypertension.
Mailland F; Groothold G; Poli A; Pantarotto C
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):567-74. PubMed ID: 2877127
[TBL] [Abstract][Full Text] [Related]
2. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
Cirino D; Savonelli C; Maggi GC
Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
[No Abstract] [Full Text] [Related]
4. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
5. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol.
De Luca N; Ricciardelli B; Groothold G; Cuocolo A; Volpe M; Trimarco B
J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371
[TBL] [Abstract][Full Text] [Related]
6. Indenolol in hypertension.
Sega R; Mailland F; Damiani E; Groothold G; Libretti A
Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
[TBL] [Abstract][Full Text] [Related]
7. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
[TBL] [Abstract][Full Text] [Related]
8. [Plasma levels and the antihypertensive effect of the preparation celiprolol].
Vlakhov N; Belovezhdov N; Terziivanov D; Koĭchev A; Stefanov G
Vutr Boles; 1986; 25(6):62-6. PubMed ID: 2951925
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
[TBL] [Abstract][Full Text] [Related]
10. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine.
Trocóniz IF; de Alwis DP; Tillmann C; Callies S; Mitchell M; Schaefer HG
Clin Pharmacol Ther; 2000 Jul; 68(1):18-27. PubMed ID: 10945312
[TBL] [Abstract][Full Text] [Related]
11. Indenolol pharmacokinetics and pharmacodynamics after single and repeated daily doses.
Sega R; Mailland F; Colombo F; Groothold G; Pantarotto C; Guenzati G; Libretti A
J Clin Pharmacol; 1985; 25(5):337-42. PubMed ID: 4031110
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.
Hedner T; Pettersson A; Persson B
J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221
[TBL] [Abstract][Full Text] [Related]
13. Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).
Venco A; Groothold G; Grandi A; Barzizza F; Corradi L; Negri F; Finardi G
Clin Ther; 1985; 7(3):347-56. PubMed ID: 3995529
[TBL] [Abstract][Full Text] [Related]
14. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
Herpin D; Boutaud P; Ciber MA; Amiel A; Demange J
Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):487-93. PubMed ID: 2892458
[TBL] [Abstract][Full Text] [Related]
15. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
Taddei S; Pedrinelli R; Salvetti A
Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
[TBL] [Abstract][Full Text] [Related]
16. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Dorow P
Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a new antihypertensive agent (indenolol) assessed by ambulatory blood pressure monitoring.
Trimarco B; Groothold G; Bonaduce D; Cuocolo A; Ricciardelli B; Canonico V; Breglio R; Condorelli M
Clin Exp Hypertens A; 1985; 7(2-3):395-9. PubMed ID: 2860987
[TBL] [Abstract][Full Text] [Related]
18. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
19. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H
Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
[TBL] [Abstract][Full Text] [Related]
20. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
